Rigel Pharmaceuticals
RIGL
RIGL
163 hedge funds and large institutions have $500M invested in Rigel Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 43 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.27% less ownership
Funds ownership: 8.32% → 8.05% (-0.27%)
19% less capital invested
Capital invested by funds: $614M → $500M (-$114M)
Holders
163
Holding in Top 10
2
Calls
$3.32M
Puts
$2.89M
Top Buyers
| 1 | +$6.41M | |
| 2 | +$4.08M | |
| 3 | +$3.4M | |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$2.18M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.05M |
Top Sellers
| 1 | -$20.5M | |
| 2 | -$7.24M | |
| 3 | -$4.06M | |
| 4 |
Millennium Management
New York
|
-$2.1M |
| 5 |
Citigroup
New York
|
-$1.54M |